Published in Contraception on October 01, 2004
Medical treatments for incomplete miscarriage (less than 24 weeks). Cochrane Database Syst Rev (2010) 2.18
[To the editor]. Contraception (2005) 0.75
Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomised controlled trial. Lancet (2007) 7.22
Method of delivery and pregnancy outcomes in Asia: the WHO global survey on maternal and perinatal health 2007-08. Lancet (2010) 6.81
Misoprostol as an adjunct to standard uterotonics for treatment of post-partum haemorrhage: a multicentre, double-blind randomised trial. Lancet (2010) 3.59
The supreme court and the Partial-Birth Abortion Ban Act of 2003: a political procedure replaces woman-centered care. MedGenMed (2007) 3.28
Where is the "E" in MCH? The need for an evidence-based approach in safe motherhood. J Midwifery Womens Health (2003) 2.36
Randomized trial of mifepristone and buccal or vaginal misoprostol for abortion through 56 days of last menstrual period. Contraception (2005) 2.17
Embracing post-fertilisation methods of family planning: a call to action. J Fam Plann Reprod Health Care (2013) 2.04
Misoprostol in the management of the third stage of labour in the home delivery setting in rural Gambia: a randomised controlled trial. BJOG (2005) 1.94
Re: Meta-analysis of 200 or 600 mg mifepristone in association with two prostaglandins for termination of early pregnancy. Contraception (2009) 1.92
Acceptability of Carraguard vaginal gel use among Thai couples. AIDS (2006) 1.65
Better than nothing or savvy risk-reduction practice? The importance of withdrawal. Contraception (2009) 1.62
Many vaginal microbicide trial participants acknowledged they had misreported sensitive sexual behavior in face-to-face interviews. J Clin Epidemiol (2008) 1.60
Infection after medical abortion: a review of the literature. Contraception (2004) 1.51
Comparing two early medical abortion regimens: mifepristone+misoprostol vs. misoprostol alone. Contraception (2010) 1.46
Misoprostol alone for early abortion: an evaluation of seven potential regimens. Contraception (2005) 1.43
Changes in prevalence, awareness, treatment and control of hypertension in Thai population, 2004-2009: Thai National Health Examination Survey III-IV. J Hypertens (2012) 1.39
Effectiveness and acceptability of medical abortion provided through telemedicine. Obstet Gynecol (2011) 1.39
Community-based kangaroo mother care to prevent neonatal and infant mortality: a randomized, controlled cluster trial. Pediatrics (2008) 1.39
Self-induction of abortion among women in the United States. Reprod Health Matters (2010) 1.35
A randomized trial of misoprostol compared with manual vacuum aspiration for incomplete abortion. Obstet Gynecol (2005) 1.31
Safety and acceptability of the candidate microbicide Carraguard in Thai Women: findings from a Phase II Clinical Trial. J Acquir Immune Defic Syndr (2006) 1.30
Epidemiological synergy of Trichomonas vaginalis and HIV in Zimbabwean and South African women. Sex Transm Dis (2010) 1.29
First-trimester medical abortion with mifepristone 200 mg and misoprostol: a systematic review. Contraception (2012) 1.27
A randomized, placebo-controlled trial to assess the safety and acceptability of use of carraguard vaginal gel by heterosexual couples in Thailand. Sex Transm Dis (2008) 1.26
Oral and injectable contraception use and risk of HIV acquisition among women in sub-Saharan Africa. AIDS (2013) 1.25
Prevalence and management of diabetes and metabolic risk factors in Thai adults: the Thai National Health Examination Survey IV, 2009. Diabetes Care (2011) 1.21
Acceptability and feasibility of medical abortion in Nepal. Int J Gynaecol Obstet (2009) 1.16
Advance provision of emergency contraception for pregnancy prevention: a meta-analysis. Obstet Gynecol (2007) 1.13
Misoprostol for women's health: a review. Obstet Gynecol (2002) 1.11
Non-physician clinicians can safely provide first trimester medical abortion. Reprod Health Matters (2009) 1.10
Mifepristone-misoprostol abortion: a trial in rural and urban Maharashtra, India. Contraception (2002) 1.10
Effects of iron supplementation on maternal hematologic status in pregnancy. Am J Public Health (2002) 1.09
Acceptability and use of the diaphragm and Replens lubricant gel for HIV prevention in Southern Africa. AIDS Behav (2009) 1.08
Cost and effectiveness evaluation of prophylactic HPV vaccine in developing countries. Value Health (2012) 1.07
The diaphragm and lubricant gel for prevention of cervical sexually transmitted infections: results of a randomized controlled trial. PLoS One (2008) 1.06
Oral misoprostol as an alternative to surgical management for incomplete abortion in Ghana. Int J Gynaecol Obstet (2010) 1.04
Assessment of service availability and health care workers' opinions about young women's sexual and reproductive health in Soweto, South Africa. Afr J Reprod Health (2012) 1.04
Male circumcision for HIV prevention: clinical practices and attitudes among healthcare providers in South Africa and Zimbabwe. Sex Transm Dis (2012) 1.03
Mifepristone and misoprostol compared with misoprostol alone for second-trimester abortion: a randomized controlled trial. Obstet Gynecol (2011) 1.02
Integrating medical abortion into safe abortion services: experience from three pilot sites in South Africa. J Fam Plann Reprod Health Care (2008) 1.01
Can mifepristone medical abortion be simplified? A review of the evidence and questions for future research. Contraception (2007) 1.01
Urban and rural variation in clustering of metabolic syndrome components in the Thai population: results from the fourth National Health Examination Survey 2009. BMC Public Health (2011) 1.01
The use of the diaphragm instead of condoms in a phase III diaphragm trial. AIDS Behav (2008) 1.00
Alternatives to a routine follow-up visit for early medical abortion. Obstet Gynecol (2010) 0.99
Medicaid funding for abortion: providers' experiences with cases involving rape, incest and life endangerment. Perspect Sex Reprod Health (2010) 0.98
Adaptation of kangaroo mother care for community-based application. J Perinatol (2003) 0.98
African women recently infected with HIV-1 and HSV-2 have increased risk of acquiring Neisseria gonorrhoeae and Chlamydia trachomatis in the Methods for Improving Reproductive Health in Africa trial. Sex Transm Dis (2011) 0.97
Medical abortion: the possibilities for introduction in the public sector in South Africa. Reprod Health Matters (2005) 0.96
Two routes of administration for misoprostol in the treatment of incomplete abortion: a randomized clinical trial. Contraception (2009) 0.96
A randomized controlled trial of 400-μg sublingual misoprostol versus manual vacuum aspiration for the treatment of incomplete abortion in two Egyptian hospitals. Int J Gynaecol Obstet (2010) 0.96
A randomized controlled study comparing 600 versus 1,200 microg oral misoprostol for medical management of incomplete abortion. Contraception (2005) 0.96
Complications after second trimester surgical and medical abortion. Reprod Health Matters (2008) 0.96
Acceptability of home-use of misoprostol in medical abortion. Contraception (2004) 0.95
Cost-effectiveness analysis of unsafe abortion and alternative first-trimester pregnancy termination strategies in Nigeria and Ghana. Afr J Reprod Health (2010) 0.95
How effective are the components of active management of the third stage of labor? BMC Pregnancy Childbirth (2013) 0.94
Misoprostol for prevention and treatment of postpartum hemorrhage: what do we know? What is next? Int J Gynaecol Obstet (2012) 0.94
Misoprostol for postpartum hemorrhage: moving from evidence to practice. Int J Gynaecol Obstet (2011) 0.94
Barriers to contraceptive use in product labeling and practice guidelines. Am J Public Health (2006) 0.93
Can at-home semi-quantitative pregnancy tests serve as a replacement for clinical follow-up of medical abortion? A US study. Contraception (2012) 0.93
Is home-based administration of prostaglandin safe and feasible for medical abortion? Results from a multisite study in Vietnam. BJOG (2004) 0.92
Willingness of clinicians to integrate microbicides into HIV prevention practices in southern Africa. AIDS Behav (2012) 0.92
Carraguard acceptability among men and women in a couples study in Thailand. J Womens Health (Larchmt) (2010) 0.92
No increase in cervicovaginal proinflammatory cytokines after Carraguard use in a placebo-controlled randomized clinical trial. J Acquir Immune Defic Syndr (2008) 0.92
Sublingual misoprostol versus standard surgical care for treatment of incomplete abortion in five sub-Saharan African countries. BMC Pregnancy Childbirth (2012) 0.92
DMPA and HIV: do we need a trial? Contraception (2014) 0.90
Interest in over-the-counter access to oral contraceptives among women in the United States. Contraception (2013) 0.90
Acceptability and feasibility of mifepristone-misoprostol for menstrual regulation in Bangladesh. Int Perspect Sex Reprod Health (2013) 0.90
A mystery caller evaluation of Medicaid staff responses about state coverage of abortion care. Womens Health Issues (2011) 0.90
Acceptability and feasibility of phone follow-up after early medical abortion in Vietnam: a randomized controlled trial. Obstet Gynecol (2014) 0.90
Multicenter trial of a simplified mifepristone medical abortion regimen. Obstet Gynecol (2005) 0.89
Fatal maternal outcome of a parturient with Eisenmenger's syndrome and severe preeclampsia. Arch Gynecol Obstet (2003) 0.89
Misoprostol as first-line treatment for incomplete abortion at a secondary-level health facility in Nigeria. Int J Gynaecol Obstet (2012) 0.89
A systematic review of the relationship between blood loss and clinical signs. PLoS One (2013) 0.89
Increasing women's choices in medical abortion: a study of misoprostol 400 microg swallowed immediately or held sublingually following 200 mg mifepristone. Eur J Contracept Reprod Health Care (2009) 0.88
Misoprostol for the prevention and treatment of postpartum hemorrhage. Expert Opin Investig Drugs (2012) 0.88
A randomized controlled trial of knowledge sharing practice with empowerment strategies in pregnant women to improve exclusive breastfeeding during the first six months postpartum. J Med Assoc Thai (2010) 0.87
An open-label randomized comparative study of oral contraceptives between medications containing 3 mg drospirenone/30 microg ethinylestradiol and 150 microg levonogestrel/30 microg ethinylestradiol in Thai women. Contraception (2004) 0.87
Results and lessons learned from a small medical abortion clinical study in Turkey. Contraception (2004) 0.87
Determinants of differential HIV incidence among women in three southern African locations. J Acquir Immune Defic Syndr (2011) 0.87
Intimate partner violence and condom and diaphragm nonadherence among women in an HIV prevention trial in southern Africa. J Acquir Immune Defic Syndr (2013) 0.86
Acceptability of home use of mifepristone for medical abortion. Contraception (2012) 0.86
Misoprostol in women's hands: a harm reduction strategy for unsafe abortion. Contraception (2012) 0.85
Diaphragm and lubricant gel acceptance, skills and patterns of use among women in an effectiveness trial in Southern Africa. Eur J Contracept Reprod Health Care (2009) 0.85
Bringing emergency contraception over the counter: experiences of nonprescription users in France, Norway, Sweden and Portugal. Contraception (2003) 0.85
As often as needed: appropriate use of emergency contraceptive pills. Contraception (2004) 0.85
Effectiveness of lifesaving skills training and improving institutional emergency obstetric care readiness in Lam Dong, Vietnam. J Midwifery Womens Health (2005) 0.85
A comparative efficacy of low-dose combined oral contraceptives containing desogestrel and drospirenone in premenstrual symptoms. Obstet Gynecol Int (2013) 0.84
Oral contraceptives and cervical cancer: critique of a recent review. Contraception (2004) 0.84
Modifying the Yuzpe regimen of emergency contraception: a multicenter randomized controlled trial. Obstet Gynecol (2003) 0.84
Twisted fallopian tube in pregnancy: a case report. BMC Pregnancy Childbirth (2001) 0.84
What happens to the women who fall through the cracks of health care reform? Lessons from Massachusetts. J Health Polit Policy Law (2012) 0.83
Expanding medical abortion in Tunisia: women's experiences from a multi-site expansion study. Contraception (2004) 0.83
Sexual function during the postpartum period. J Med Assoc Thai (2007) 0.83
A comparative study of monophasic oral contraceptives containing either drospirenone 3 mg or levonorgestrel 150 microg on premenstrual symptoms. Contraception (2005) 0.83
The effect of the vaginal diaphragm and lubricant gel on acquisition of HSV-2. Sex Transm Infect (2011) 0.83
Comparison of misoprostol-only and combined mifepristone-misoprostol regimens for home-based early medical abortion in Tunisia and Vietnam. Int J Gynaecol Obstet (2012) 0.82